Other Equity - Cartesian Therapeutics Inc (NASDAQ:RNAC) - Alpha Spread

Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 16.54 USD 5.82% Market Closed
Market Cap: 353.6m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Cartesian Therapeutics Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cartesian Therapeutics Inc
Other Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Cartesian Therapeutics Inc
NASDAQ:RNAC
Other Equity
-$4.6m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Equity
-$2.5B
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
-20%
Gilead Sciences Inc
NASDAQ:GILD
Other Equity
$93m
CAGR 3-Years
32%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Equity
-$155m
CAGR 3-Years
44%
CAGR 5-Years
21%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Equity
$38m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Equity
-$69.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Cartesian Therapeutics Inc's Other Equity?
Other Equity
-4.6m USD

Based on the financial report for Jun 30, 2024, Cartesian Therapeutics Inc's Other Equity amounts to -4.6m USD.

What is Cartesian Therapeutics Inc's Other Equity growth rate?
Other Equity CAGR 5Y
0%

Over the last year, the Other Equity growth was 0%.

Back to Top